Corporate Symposia - Non-CME


Monday, July 25

The Fairmont – Canadian Ballroom
6:30 – 9 p.m.

Redefining When Alzheimer's Disease Begins: Implications for Future Treatments

Leading experts will explore historical perspectives of AD and evolution of its diagnosis: latest thinking in diagnosis and treatment; preclinical criteria; next steps to early intervention; learnings from genetically defined populations; what can be understood from sporadic AD. Recent changes in diagnostic paradigm; biomarkers; innovative trial platforms, ethics.

Sponsored by: Janssen Research & Development LLC.

Monday, July 25

The Westin Harbour Castle Hotel – Frontenac Ballroom
6:30 – 8 p.m.

Transforming Clinical Trials in Alzheimer's Disease: Innovations and Partnerships

Alzheimer's disease (AD) clinical trials need major updates. An international expert panel will explore the current issues and highlight key approaches that are transforming AD trials: fast-start networks and trial-ready cohorts to accelerate recruitment, biomarker tools to aid patient identification and community partnerships across clinical, research and patient groups.

Sponsored by: F. Hoffmann-La Roche Ltd.

Tuesday, July 26

The Westin Harbour Castle Hotel – Frontenac Ballroom
6 – 9 p.m.

The Metabolic Hypothesis of AD: Past, Present and Future

The symposium will highlight the latest research on the metabolic hypothesis of Alzheimer's disease (AD). Speakers will present the need for innovative and alternative approaches to AD drug development and how the metabolic hypothesis of AD is providing exciting new potential therapies, several with near term clinical data readout.

Sponsored by: Accera®

Tuesday, July 26

The Fairmont Royal York Hotel – Canadian Ballroom
6 – 9 p.m.

Neuropsychiatric Symptoms and Alzheimer's Disease: Current and Future Perspectives

Join the experts and your peers for dinner and discussion about neuropsychiatric symptoms of Alzheimer's disease and the current challenges in patient assessment and diagnosis. The distinguished faculty will outline the need for standardized assessment tools and outcomes measures, review current treatment options and highlight unmet clinical and patient needs.

Sponsored by: Avanir® Pharmaceuticals

Wednesday, July 27

The Fairmont Royal York Hotel – Canadian Ballroom
6 – 8:30 p.m.

The Debate Continues: Unraveling the Science of Alzheimer's Disease

To unravel the science of Alzheimer's disease, a group of esteemed faculty will question timely topics—disease pathways, mechanisms and treatment goals—while providing supporting data within the context of an exciting, engaging debate. This signature event will close with a thought-provoking keynote discussion. Space is limited, please pre-register.

Sponsored by: Axovant

AAIC 2016
Attendee App

View abstracts, schedule & more!

> Learn more about the app.

> Using another device? Get details here.

Join the Conversation #AAIC16